CTAGE2 Antibodies

Santa Cruz Biotechnology delivers a wide array of CTAGE2 monoclonal antibodies for various research applications. CTAGE2 monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CTAGE2, or Cancer/Testis Antigen 2, plays a significant role in tumor biology and is primarily expressed in testicular germ cells and various cancer tissues. CTAGE2 expression is often associated with tumor progression and can serve as a potential biomarker for certain malignancies. Understanding CTAGE2 function is crucial for developing targeted therapies and improving diagnostic strategies in oncology. CTAGE2 monoclonal antibodies enable precise detection and characterization of CTAGE2 expression patterns across different tissue types. Researchers utilizing CTAGE2 monoclonal antibodies can explore cellular mechanisms involved in cancer development and progression. The reliability and specificity of Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing cancer research and therapeutic development.